Health Sciences Acquisitions Co. 2 (HSAQ) Competitors $3.12 -0.04 (-1.27%) As of 07/30/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsInsider TradesSEC FilingsTrendsBuy This Stock HSAQ vs. INFU, NSPR, CTCX, TMDIF, GBS, PETV, RVP, BTCY, INVO, and NAYAShould you be buying Health Sciences Acquisitions Co. 2 stock or one of its competitors? The main competitors of Health Sciences Acquisitions Co. 2 include InfuSystem (INFU), InspireMD (NSPR), Carmell (CTCX), Titan Medical (TMDIF), GBS (GBS), PetVivo (PETV), Retractable Technologies (RVP), Biotricity (BTCY), INVO Bioscience (INVO), and NAYA Biosciences (NAYA). These companies are all part of the "surgical & medical instruments" industry. Health Sciences Acquisitions Co. 2 vs. Its Competitors InfuSystem InspireMD Carmell Titan Medical GBS PetVivo Retractable Technologies Biotricity INVO Bioscience NAYA Biosciences Health Sciences Acquisitions Co. 2 (NASDAQ:HSAQ) and InfuSystem (NYSE:INFU) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, risk, earnings, dividends, institutional ownership, media sentiment, profitability and analyst recommendations. Which has more risk & volatility, HSAQ or INFU? Health Sciences Acquisitions Co. 2 has a beta of 0.09, suggesting that its share price is 91% less volatile than the S&P 500. Comparatively, InfuSystem has a beta of 1.81, suggesting that its share price is 81% more volatile than the S&P 500. Is HSAQ or INFU more profitable? InfuSystem has a net margin of 1.12% compared to Health Sciences Acquisitions Co. 2's net margin of 0.00%. InfuSystem's return on equity of 2.78% beat Health Sciences Acquisitions Co. 2's return on equity.Company Net Margins Return on Equity Return on Assets Health Sciences Acquisitions Co. 2N/A N/A -2.38% InfuSystem 1.12%2.78%1.41% Which has better valuation & earnings, HSAQ or INFU? InfuSystem has higher revenue and earnings than Health Sciences Acquisitions Co. 2. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHealth Sciences Acquisitions Co. 2N/AN/A-$380KN/AN/AInfuSystem$137.58M0.87$870K$0.1440.71 Do analysts prefer HSAQ or INFU? InfuSystem has a consensus price target of $12.50, suggesting a potential upside of 119.30%. Given InfuSystem's stronger consensus rating and higher possible upside, analysts plainly believe InfuSystem is more favorable than Health Sciences Acquisitions Co. 2.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Health Sciences Acquisitions Co. 2 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00InfuSystem 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 3 Strong Buy rating(s) 4.00 Does the media prefer HSAQ or INFU? In the previous week, InfuSystem had 1 more articles in the media than Health Sciences Acquisitions Co. 2. MarketBeat recorded 1 mentions for InfuSystem and 0 mentions for Health Sciences Acquisitions Co. 2. InfuSystem's average media sentiment score of 0.66 beat Health Sciences Acquisitions Co. 2's score of 0.00 indicating that InfuSystem is being referred to more favorably in the news media. Company Overall Sentiment Health Sciences Acquisitions Co. 2 Neutral InfuSystem Positive Do institutionals and insiders hold more shares of HSAQ or INFU? 89.7% of Health Sciences Acquisitions Co. 2 shares are owned by institutional investors. Comparatively, 71.1% of InfuSystem shares are owned by institutional investors. 21.9% of Health Sciences Acquisitions Co. 2 shares are owned by company insiders. Comparatively, 11.4% of InfuSystem shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. SummaryInfuSystem beats Health Sciences Acquisitions Co. 2 on 11 of the 13 factors compared between the two stocks. Get Health Sciences Acquisitions Co. 2 News Delivered to You Automatically Sign up to receive the latest news and ratings for HSAQ and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HSAQ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HSAQ vs. The Competition Export to ExcelMetricHealth Sciences Acquisitions Co. 2Surgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$34.98M$62.68M$5.47B$9.53BDividend YieldN/AN/A4.74%4.08%P/E RatioN/A6.2128.6723.80Price / SalesN/A106.68422.2688.08Price / CashN/A18.4135.4557.96Price / Book-5.037.408.275.55Net Income-$380K-$25.35M$3.24B$259.03M7 Day Performance-5.17%-4.60%-3.63%-4.56%1 Month Performance12.64%5.28%4.40%4.49%1 Year Performance-54.45%48.66%25.97%18.05% Health Sciences Acquisitions Co. 2 Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HSAQHealth Sciences Acquisitions Co. 2N/A$3.12-1.3%N/A-54.5%$34.98MN/A0.004INFUInfuSystem2.8399 of 5 stars$5.68+3.0%$12.50+120.3%N/A$119.58M$137.58M94.85410NSPRInspireMD2.9691 of 5 stars$2.50-1.0%$4.50+80.4%-7.6%$76.43M$7.03M-3.3350News CoverageCTCXCarmellN/A$3.63-16.0%N/A+178.1%$75.89M$32.84K0.0014Gap UpTMDIFTitan MedicalN/A$0.38+2.8%N/A+934.6%$43.37M$17.63M-0.3050GBSGBSN/A$2.15+0.5%N/A+12.3%$32.01MN/A-3.847PETVPetVivoN/A$0.85+1.9%N/A+30.2%$20.68M$1.05M-1.8820Gap DownRVPRetractable Technologies2.8739 of 5 stars$0.69+3.1%N/A-33.7%$20.51M$33.75M-1.27240News CoveragePositive NewsGap DownBTCYBiotricityN/A$0.51+6.3%N/A-40.4%$12.71M$12.06M-0.4740Gap UpINVOINVO BioscienceN/A$2.55+0.9%N/AN/A$9.71M$5.77M0.0025Gap UpNAYANAYA BiosciencesN/A$2.55+0.9%$24.00+841.2%N/A$1.70M$6.23M0.0010Gap UpHigh Trading Volume Related Companies and Tools Related Companies InfuSystem Competitors InspireMD Competitors Carmell Competitors Titan Medical Competitors GBS Competitors PetVivo Competitors Retractable Technologies Competitors Biotricity Competitors INVO Bioscience Competitors NAYA Biosciences Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HSAQ) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | SponsoredTrump’s crypto advisor may have revealed the next big crypto opportunityWhile investors chase Bitcoin toward $100K, D.C. insiders are quietly loading up on something else. One of Tru...Weiss Ratings | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredToo busy to trade? Good.Too busy to trade? That might be your edge. This after-hours strategy is built for people who don’t sit at ...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Health Sciences Acquisitions Co. 2 Please log in to your account or sign up in order to add this asset to your watchlist. Share Health Sciences Acquisitions Co. 2 With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HSAQ Stock Alerts